Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 429,224 |
|
|||||
| News | - | ||||||
| Day High | 4.45 | Low High |
|||||
| Day Low | 4.24 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Applied Therapeutics Inc | APLT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.05 | 1.18% | 4.28 | 18:30:49 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.33 | 4.24 | 4.45 | 4.28 | 4.23 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,417 | 429,224 | $ 4.36 | $ 1,871,239 | - | 1.18 - 9.39 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:46:57 | 1 | $ 4.28 | USD |
Applied Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 454.25M | 105.89M | - | 9.99M | -119.76M | -1.13 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Applied Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical APLT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.72 | 4.8887 | 4.165 | 4.37 | 1,149,086 | -0.44 | -9.32% |
| 1 Month | 6.00 | 6.70 | 4.165 | 5.25 | 964,157 | -1.72 | -28.67% |
| 3 Months | 3.10 | 9.39 | 2.585 | 5.62 | 1,891,294 | 1.18 | 38.06% |
| 6 Months | 2.78 | 9.39 | 1.79 | 4.31 | 1,585,573 | 1.50 | 53.96% |
| 1 Year | 1.36 | 9.39 | 1.18 | 3.65 | 1,101,627 | 2.92 | 214.71% |
| 3 Years | 16.59 | 25.59 | 0.4995 | 3.59 | 542,606 | -12.31 | -74.20% |
| 5 Years | 8.04 | 57.39 | 0.4995 | 7.39 | 383,048 | -3.76 | -46.77% |
Applied Therapeutics Description
| Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic exposure and peripheral nerve permeability, developed for the treatment of diabetic cardiomyopathy, or DbCM, a fatal fibrosis of the heart. |
